This document comprises a surgical consensus of evidence-based guidelines to provide local recommendations on contemporary real-world best practices for screening, diagnosis, staging, multimodal management (including neoadjuvant, perioperative ‘sandwich’ and adjuvant therapy regimens), operative procedures and post-resection surveillance for early-stage resectable (stages 1A-IIIB-N2) non-small cell lung cancer (NSCLC).